VK
Varinder Kumar
About Varinder Kumar
Data last updated:
Varinder Kumar has 2 years in corporate governance. Holds Director role. Currently with 2 companies, including Esroford Pharmaceuticals Private Limited and Skyever Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Skyever Pharmaceuticals Private Limited at ₹1.01 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 22 Aug 2024 | 2020 | ₹1.01 Cr (FY 2024) | Active | |
| Director | 28 Nov 2024 | 2024 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Varinder Kumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Varinder Kumar
Varinder Kumar has 2 years in corporate governance. Holds Director role. Currently with 2 companies, including Esroford Pharmaceuticals Private Limited and Skyever Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Skyever Pharmaceuticals Private Limited at ₹1.01 Cr (FY 2024).
Varinder Kumar is associated with 2 companies as Director, including Skyever Pharmaceuticals Private Limited (₹1.01 Cr), Esroford Pharmaceuticals Private Limited.
Varinder Kumar has expertise in General Business.
Varinder Kumar has 2 years in corporate governance.
By reported revenue, the largest current company of Varinder Kumar is Skyever Pharmaceuticals Private Limited, with revenue of ₹1.01 Cr (FY 2024).
Varinder Kumar currently holds positions at 2 companies: Skyever Pharmaceuticals Private Limited (₹1.01 Cr), Esroford Pharmaceuticals Private Limited.